Upcoming Policies Effective September 1 2025
Natiijooyinka Raadinta
Soo bandhiga 2871 - 2880 ee natiijooyinka 4229
Bixiye
QP60-25 MHCP Pharmacy Benefit Exclusion for Emrelis™, Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP59-25 Commercial Pharmacy Benefit Exclusion for Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP58-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP57-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2025
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP56-25 MHCP Enhanced Authorization Submissions through Availity Essentials
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025
Bixiye
QP55-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda dhaqangalka Barnaamijka: Jul 09, 2025